OBJECTIVES: To develop recommendations for the management of adult and paediatric lupus nephritis (LN). METHODS: The available evidence was systematically reviewed using the PubMed database. A modified Delphi method was used to compile questions, elicit expert opinions and reach consensus. RESULTS: Immunosuppressive treatment should be guided by renal biopsy, and aiming for complete renal response (proteinuria <0.5 g/24 h with normal or near-normal renal function). Hydroxychloroquine is recommended for all patients with LN. Because of a more favourable efficacy/toxicity ratio, as initial treatment for patients with class III-IV(A) or (A/C) (\ub1V) LN according to the International Society of Nephrology/Renal Pathology Society 2003 classific...
OBJECTIVE: To update the 2012 EULAR/ERA-EDTA recommendations for the management of lupus nephritis (...
Objective To update the 2012 EULAR/ERA-EDTA recommendations for the management of lupus nephritis (L...
Objective To update the 2012 EULAR/ERA-EDTA recommendations for the management of lupus nephritis (L...
OBJECTIVES: To develop recommendations for the management of adult and paediatric lupus nephritis (L...
OBJECTIVES: To develop recommendations for the management of adult and paediatric lupus nephritis (L...
OBJECTIVES: To develop recommendations for the management of adult and paediatric lupus nephritis (L...
Item does not contain fulltextOBJECTIVES: To develop recommendations for the management of adult and...
Objectives To develop recommendations for the management of adult and paediatric lupus nephritis (LN...
Objectives To develop recommendations for the management of adult and paediatric lupus nephritis (LN...
Objectives To develop recommendations for the management of adult and paediatric lupus nephritis (LN...
Objectives To develop recommendations for the management of adult and paediatric lupus nephritis (LN...
Recommendations for the management of LN were developed using an evidence-based approach followed by...
OBJECTIVES: To analyse the current evidence for the management of lupus nephritis (LN) informing the...
Objective: To update the 2012 EULAR/ERA-EDTA recommendations for the management of lupus nephritis (...
OBJECTIVE: To update the 2012 EULAR/ERA-EDTA recommendations for the management of lupus nephritis (...
OBJECTIVE: To update the 2012 EULAR/ERA-EDTA recommendations for the management of lupus nephritis (...
Objective To update the 2012 EULAR/ERA-EDTA recommendations for the management of lupus nephritis (L...
Objective To update the 2012 EULAR/ERA-EDTA recommendations for the management of lupus nephritis (L...
OBJECTIVES: To develop recommendations for the management of adult and paediatric lupus nephritis (L...
OBJECTIVES: To develop recommendations for the management of adult and paediatric lupus nephritis (L...
OBJECTIVES: To develop recommendations for the management of adult and paediatric lupus nephritis (L...
Item does not contain fulltextOBJECTIVES: To develop recommendations for the management of adult and...
Objectives To develop recommendations for the management of adult and paediatric lupus nephritis (LN...
Objectives To develop recommendations for the management of adult and paediatric lupus nephritis (LN...
Objectives To develop recommendations for the management of adult and paediatric lupus nephritis (LN...
Objectives To develop recommendations for the management of adult and paediatric lupus nephritis (LN...
Recommendations for the management of LN were developed using an evidence-based approach followed by...
OBJECTIVES: To analyse the current evidence for the management of lupus nephritis (LN) informing the...
Objective: To update the 2012 EULAR/ERA-EDTA recommendations for the management of lupus nephritis (...
OBJECTIVE: To update the 2012 EULAR/ERA-EDTA recommendations for the management of lupus nephritis (...
OBJECTIVE: To update the 2012 EULAR/ERA-EDTA recommendations for the management of lupus nephritis (...
Objective To update the 2012 EULAR/ERA-EDTA recommendations for the management of lupus nephritis (L...
Objective To update the 2012 EULAR/ERA-EDTA recommendations for the management of lupus nephritis (L...